HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Dynavax Technologies Corporation +6.35% Pre
Dynavax Technologies Corporation DVAX | 11.39 11.39 | +6.35% 0.00% Pre |
HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:
DVAX) with a Buy and maintains $29 price target.